Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hikma Pharmaceuticals Plc Agrees To Acquires Egyptian Company For Pharmaceuticals & Chemical Industries


Wednesday, 9 Jan 2013 02:00am EST 

Hikma Pharmaceuticals Plc announced that it has agreed to acquire the Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI) from a consortium of shareholders. Hikma will pay an aggregate cash consideration of EGP142.4 million upon closing, or approximately USD22.2 million, based on the current exchange rate. Closing is expected to occur before February 14, 2013 and is conditional on fulfillment of conditions precedent. 

Company Quote

2032.0
-11.0 -0.54%
19 Dec 2014